
Syndyma 400mg/16ml Injection
Manufacturer
Cipla Ltd
Salt Composition
Bevacizumab (25mg/ml)
Key Information
Short Description
Syndyma 400mg/16ml Injection is an anticancer medication used to treat various types of cancer, including colon and rectum, non-small cell lung, kidney, brain, ovarian, and cervical cancer.
Dosage Form
Solution for Infusion
Introduction
Syndyma 400mg/16ml Injection is an effective medicine and first-line option when used together with other cancer medicines. It is given as an infusion, and your doctor will decide your dose and duration. You may experience side effects such as rectal bleeding, taste change, and headache. Inform your doctor if you notice any unusual bleeding or bleeding that doesn't stop easily. You may be advised to check blood pressure and levels of protein in urine while taking this medication.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How it works
Syndyma 400mg/16ml Injection is a anti-angiogenic medication that works by blocking a protein called vascular endothelial growth factor (VEGF), which stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
Quick Tips
Syndyma 400mg/16ml Injection is an effective medicine First-line option when used together with other medicines for certain types of cancers Given as an infusion May lower wound healing ability May increase risk of bleeding